Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy

References

• Aarsland, D., Litvan, I. & Larsen, J.P. (2001). Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 42–49.
   PubMed Web of Science ®Google Scholar
• Armstrong, M.J., Litvan, I., Lang, A.E., Bak, T.H., Bhatia, K.P., Borroni, B., … Weiner, W.J. (2013). Criteria for the diagnosis of corticobasal degeneration. [Multicenter Study Research Support, Non-U.S. Gov't]. Neurology, 80, 496–503.
   PubMed Web of Science ®Google Scholar
• Bak, T.H., Caine, D., Hearn, V.C. & Hodges, J.R. (2006). Visuospatial functions in atypical Parkinsonian syndromes. Journal of Neurology, Neurosurgery, and Psychiatry, 77, 454–456.
   PubMed Web of Science ®Google Scholar
• Bak, T.H., Crawford, L.M., Berrios, G. & Hodges, J.R. (2010). Behavioural symptoms in progressive supranuclear palsy and frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 81, 1057–1059.
   PubMed Web of Science ®Google Scholar
• Bak, T.H., & Hodges, J.R. (2008). Corticobasal degeneration: clinical aspects. Handbook of clinical neurology/ edited by P.J. Vinken and G.W. Bruyn, 89, 509–521.
   PubMedGoogle Scholar
• Bergeron, C., Pollanen, M.S., Weyer, L. & Lang, A.E. (1997). Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. Journal of Neuropathology and Experimental Neurology, 56 , 726–734.
   PubMed Web of Science ®Google Scholar
• Blin, J., Baron, J.C., Dubois, B., Pillon, B., Cambon, H., Cambier, J. & Agid, Y. (1990). Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Archives of Neurology, 47, 747–752.
   PubMedGoogle Scholar
• Boeve, B.F. (2012). Progressive supranuclear palsy. Parkinsonism and Related Disorders, 18, S192–194.
   PubMed Web of Science ®Google Scholar
• Boeve, B.F., Lang, A.E. & Litvan, I. (2003). Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Annals of Neurology, 54(S5), S15–19.
   Google Scholar
• Borroni, B., Alberici, A., Agosti, C., Cosseddu, M., & Padovani, A. (2009). Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy. [Comparative Study]. International Psychogeriatrics/IPA, 21, 463–468.
   PubMed Web of Science ®Google Scholar
• Borroni, B., Turla, M., Bertasi, V., Agosti, C., Gilberti, N., & Padovani, A. (2008). Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. [Comparative Study Multicenter Study]. Archives of gerontology and geriatrics, 47, 53–61.
   PubMed Web of Science ®Google Scholar
• Boxer, A.L., Geschwind, M.D., Belfor, N., Gorno-Tempini, M.L., Schauer, G.F., Miller, B.L., … Rosen, H.J. (2006). Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Archives of Neurology, 63, 81–86.
   PubMed Web of Science ®Google Scholar
• Chan, M. (Producer) (2012). Dementia: A public health priority. Retrieved from http://whqlibdoc.who.int/publications/2012/9789241564458_eng.pdf.
   Google Scholar
• Cole, D.G. & Growdon, J.H. (1994). Therapy for progressive supranuclear palsy: Past and future. Journal of Neural Transmission. Supplementum, 42, 283–290.
   PubMedGoogle Scholar
• Cummings, J.L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D.A. & Gornbein, J. (1994). The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308–2314.
   PubMed Web of Science ®Google Scholar
• Daniel, S.E., de Bruin, V.M., & Lees, A.J. (1995). The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. [Comparative Study Research Support, Non-U.S. Gov't Review]. Brain : A Journal of Neurology, 118, 759–770.
   PubMed Web of Science ®Google Scholar
• Dickson, D.W., Ahmed, Z., Algom, A.A., Tsuboi, Y. & Josephs, K.A. (2010). Neuropathology of variants of progressive supranuclear palsy. Current Opinion in Neurology, 23, 394–400.
   PubMed Web of Science ®Google Scholar
• Dickson, D.W., Bergeron, C., Chin, S.S., Duyckaerts, C., Horoupian, D., Ikeda, K., … Litvan, I. (2002). Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. Journal of Neuropathology and Experimental Neurology, 61, 935–946.
   PubMed Web of Science ®Google Scholar
• Dickson, D.W., Rademakers, R. & Hutton, M.L. (2007). Progressive supranuclear palsy: Pathology and genetics. Brain Pathology, 17, 74–82.
   PubMed Web of Science ®Google Scholar
• Dubois, B., Pillon, B., Legault, F., Agid, Y. & Lhermitte, F. (1988). Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Archives of Neurology, 45, 1194–1199.
   PubMed Web of Science ®Google Scholar
• Esmonde, T., Giles, E., Gibson, M. & Hodges, J.R. (1996). Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. Journal of Neurology, 243, 638–643.
   PubMed Web of Science ®Google Scholar
• Geda, Y.E., Boeve, B.F., Negash, S., Graff-Radford, N.R., Knopman, D.S., Parisi, J.E., … Petersen, R.C. (2007). Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. Journal of Neuropsychiatry and Clinical Neurosciences, 19, 77–80.
   PubMed Web of Science ®Google Scholar
• Grober, E., Dickson, D., Sliwinski, M.J., Buschke, H., Katz, M., Crystal, H. & Lipton, R. B. (1999). Memory and mental status correlates of modified Braak staging. Neurobiology of Aging, 20, 573–579.
   PubMed Web of Science ®Google Scholar
• Gunning, F.M., Cheng, J., Murphy, C.F., Kanellopoulos, D., Acuna, J., Hoptman, M.J., … Alexopoulos, G.S. (2009). Anterior cingulate cortical volumes and treatment remission of geriatric depression. International Journal of Geriatric Psychiatry, 24, 829–836.
   PubMed Web of Science ®Google Scholar
• Hadavi, S., Noyce, A.J., Leslie, R.D. & Giovannoni, G. (2011). Stiff person syndrome. Practical Neurology, 11, 272–282.
   PubMedGoogle Scholar
• Hargrave, R. & Rafal, R. (1998). Depression in corticobasal degeneration. Psychosomatics, 39, 481–482.
   PubMed Web of Science ®Google Scholar
• Hauw, J.J., Daniel, S.E., Dickson, D., Horoupian, D.S., Jellinger, K., Lantos, P.L., … Litvan, I. (1994). Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). Neurology, 44, 2015–2019.
   PubMed Web of Science ®Google Scholar
• Hoehn-Saric, R., Harris, G.J., Pearlson, G.D., Cox, C.S., Machlin, S.R. & Camargo, E.E. (1991). A fluoxetine-induced frontal lobe syndrome in an obsessive compulsive patient. Journal of Clinical Psychiatry, 52, 131–133.
   PubMed Web of Science ®Google Scholar
• Hoehn-Saric, R., Lipsey, J.R. & McLeod, D.R. (1990). Apathy and indifference in patients on fluvoxamine and fluoxetine. Journal of Clinical Psychopharmacology, 10, 343–345.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A. & Dickson, D.W. (2003). Diagnostic accuracy of progressive supranuclear palsy in the society for progressive supranuclear palsy brain bank. Movement Disorders, 18, 1018–1026.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Eggers, S.D., Jack, C.R., Jr & Whitwell, J.L. (2012). Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid. European Journal of Neurology, 19, 1440–1446.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Jr, Whitwell, J.L., Weigand, S.D., Senjem, M.L., Boeve, B.F., Knopman, D.S., … Petersen, R.C. (2011). Predicting functional decline in behavioural variant frontotemporal dementia. Brain, 134, 432–448.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Petersen, R.C., Knopman, D.S., Boeve, B.F., Whitwell, J.L., Duffy, J.R., … Dickson, D.W. (2006). Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology, 66, 41–48.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Tang-Wai, D.F., Edland, S.D., Knopman, D.S., Dickson, D.W., Parisi, J.E., … Boeve, B.F. (2004). Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Archives of Neurology, 61, 1881–1884.
   PubMedGoogle Scholar
• Josephs, K.A., Whitwell, J.L., Dickson, D.W., Boeve, B.F., Knopman, D.S., Petersen, R.C., … Jack, C.R., Jr (2008). Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiology of Aging, 29, 280–289.
   PubMed Web of Science ®Google Scholar
• Josephs, K.A., Whitwell, J.L., Eggers, S.D., Senjem, M.L. & Jack, C.R., Jr (2011). Gray matter correlates of behavioral severity in progressive supranuclear palsy. Movement disorders, 26, 493–498.
   PubMed Web of Science ®Google Scholar
• Juh, R., Pae, C.U., Kim, T.S., Lee, C.U., Choe, B., & Suh, T. (2005). Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. [Comparative Study Research Support, Non-U.S. Gov't]. Neuroscience letters, 383, 22–27.
   PubMed Web of Science ®Google Scholar
• Kemp, W.L., Fitzgerald, J. & White, C.L., III. (2007). Undiagnosed progressive supranuclear palsy in a patient with neuroleptic malignant syndrome due to use of neuroleptics: The utility of autopsy in deaths due to known drug reactions American Journal of Forensic Medicine and Pathology, 28, 59–62.
   PubMed Web of Science ®Google Scholar
• Kertesz, A. & McMonagle, P. (2010). Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. Journal of the Neurological Sciences, 289, 138–143.
   PubMed Web of Science ®Google Scholar
• Kertesz, A., McMonagle, P. & Jesso, S. (2011). Extrapyramidal syndromes in frontotemporal degeneration. Journal of Molecular Neuroscience, 45, 336–342.
   PubMed Web of Science ®Google Scholar
• Klaffke, S., Kuhn, A.A., Plotkin, M., Amthauer, H., Harnack, D., Felix, R. & Kupsch, A. (2006). Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Movement Disorders, 21, 1724–1727.
   PubMed Web of Science ®Google Scholar
• Lang, A.E., Riley, D.E., Bergeron, C. (1994). Cortico-Basal Ganglionic Degeneration. Philadelphia, PA: Saunders.
   Google Scholar
• Levy, M.L., Cummings, J.L., Fairbanks, L.A., Masterman, D., Miller, B.L., Craig, A.H., … Litvan, I. (1998). Apathy is not depression. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 314–319.
   PubMed Web of Science ®Google Scholar
• Ling, H., O’Sullivan, S.S., Holton, J.L., Revesz, T., Massey, L.A., Williams, D.R., … Lees, A.J. (2010). Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain, 133, 2045–2057. doi: 10.1093/brain/awq123.
   PubMed Web of Science ®Google Scholar
• Litvan, I., Cummings, J.L. & Mega, M. (1998). Neuropsychiatric features of corticobasal degeneration. Journal of Neurology, Neurosurgery, and Psychiatry, 65, 717–721.
   PubMed Web of Science ®Google Scholar
• Litvan, I., Grimes, D.A., Lang, A.E., Jankovic, J., McKee, A., Verny, M., … Pearce, R.K. (1999). Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology, 246 (S2 II), 1–5. doi: 9246S001.415 [pii]
   Google Scholar
• Litvan, I., Mega, M.S., Cummings, J.L. & Fairbanks, L. (1996). Neuropsychiatric aspects of progressive supranuclear palsy. Neurology, 47, 1184–1189.
   PubMed Web of Science ®Google Scholar
• Litvan, I., Agid, Y., Goetz, C., Jankovic, J., Wenning, G.K., Brandel, J.P., … Bartko, J.J. (1997). Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. [Review]. Neurology, 48, 119–125.
   PubMed Web of Science ®Google Scholar
• Litvan, I., Cummings, J. L., & Mega, M. (1998). Neuropsychiatric features of corticobasal degeneration. [Comparative Study Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Journal of Neurology, Neurosurgery, and Psychiatry, 65, 717–721.
   PubMed Web of Science ®Google Scholar
• Litvan, I., Phipps, M., Pharr, V.L., Hallett, M., Grafman, J. & Salazar, A. (2001). Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology, 57, 467–473.
   PubMed Web of Science ®Google Scholar
• Margari, F., Sicolo, M., Spinelli, L., Mastroianni, F., Pastore, A., Craig, F. & Petruzzelli, M.G. (2012). Aggressive behavior, cognitive impairment, and depressive symptoms in elderly subjects. Neuropsychiatric Disease and Treatment, 8, 347–353.
   PubMed Web of Science ®Google Scholar
• Massman, P.J., Kreiter, K.T., Jankovic, J., & Doody, R.S. (1996). Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology, 46, 720–726.
   PubMed Web of Science ®Google Scholar
• Mathew, R., Bak, T.H. & Hodges, J.R. (2012). Diagnostic criteria for corticobasal syndrome: A comparative study. Journal of Neurology, Neurosurgery, and Psychiatry, 83, 405–410.
   PubMed Web of Science ®Google Scholar
• McKhann, G.M., Albert, M.S., Grossman, M., Miller, B., Dickson, D. & Trojanowski, J.Q. (2001). Clinical and pathological diagnosis of frontotemporal dementia: Report of the work group on frontotemporal dementia and Pick's disease. Archives of Neurology, 58, 1803–1809.
   PubMed Web of Science ®Google Scholar
• Menza, M.A., Cocchiola, J., & Golbe, L.I. (1995). Psychiatric symptoms in progressive supranuclear palsy. Psychosomatics, 36, 550–554.
   PubMed Web of Science ®Google Scholar
• Meyer, J.H. (2012). Neuroimaging markers of cellular function in major depressive disorder: Implications for therapeutics, personalized medicine, and prevention. Clinical Pharmacology and Therapeutics, 91, 201–214.
   PubMed Web of Science ®Google Scholar
• Mimura, M., White, R.F. & Albert, M.L. (1997). Corticobasal degeneration: Neuropsychological and clinical correlates. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 94–98.
   PubMed Web of Science ®Google Scholar
• Neary, D., Snowden, J.S., Gustafson, L., Passant, U., Stuss, D., Black, S., … Benson, D.F. (1998). Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology, 51, 1546–1554.
   PubMed Web of Science ®Google Scholar
• Nikolaus, S., Antke, C. & Muller, H.W. (2009). In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia. Behavioural Brain Research, 204, 1–31.
   PubMed Web of Science ®Google Scholar
• Nomura, T., Inoue, Y., Takigawa, H. & Nakashima, K. (2012). Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease. Parkinsonism and Related Disorders, 18, 394–396.
   PubMed Web of Science ®Google Scholar
• Nunnemann, S., Kurz, A., Leucht, S. & Diehl-Schmid, J. (2012). Caregivers of patients with frontotemporal lobar degeneration: A review of burden, problems, needs, and interventions. International Psychogeriatrics, 24, 1368–1386.
   PubMed Web of Science ®Google Scholar
• Oide, T., Ohara, S., Yazawa, M., Inoue, K., Itoh, N., Tokuda, T. & Ikeda, S. (2002). Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. Acta neuropathologica, 104, 209–214.
   PubMed Web of Science ®Google Scholar
• Padala, P.R., Padala, K.P., Monga, V., Ramirez, D.A. & Sullivan, D.H. (2012). Reversal of SSRI-associated apathy syndrome by discontinuation of therapy. Annals of pharmacotherapy, 46, e8.
   Google Scholar
• Palmer, K., Lupo, F., Perri, R., Salamone, G., Fadda, L., Caltagirone, C., … Cravello, L. (2011). Predicting disease progression in Alzheimer's disease: The role of neuropsychiatric syndromes on functional and cognitive decline. Journal of Alzheimer's Disease, 24, 35–45.
   PubMed Web of Science ®Google Scholar
• Peters, M.E., Rosenberg, P.B., Steinberg, M., Norton, M.C., Welsh-Bohmer, K.A., Hayden, K.M., … Lyketsos, C.G. (2012). Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: The Cache County study. American Journal of Geriatric Psychiatry, 20, 416–424.
   PubMed Web of Science ®Google Scholar
• Pillon, B., Blin, J., Vidailhet, M., Deweer, B., Sirigu, A., Dubois, B., & Agid, Y. (1995). The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology, 45, 1477–1483.
   PubMed Web of Science ®Google Scholar
• Rankin, K.P., Mayo, M.C., Seeley, W.W., Lee, S., Rabinovici, G., Gorno-Tempini, M.L., … Miller, B.L. (2011). Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: Phenotypic comparison to bvFTD with Pick's disease. Journal of Molecular Neuroscience, 45, 594–608.
   PubMed Web of Science ®Google Scholar
• Rebeiz, J.J., Kolodny, E.H. & Richardson, E.P., Jr (1968). Corticodentatonigral degeneration with neuronal achromasia. Archives of Neurology, 18, 20–33.
   PubMedGoogle Scholar
• Revesz, T., Sangha, H. & Daniel, S.E. (1996). The nucleus raphe interpositus in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Brain, 119, 1137–1143.
   PubMed Web of Science ®Google Scholar
• Sadowsky, C.H. & Galvin, J.E. (2012). Guidelines for the management of cognitive and behavioral problems in dementia. Journal of the American Board of Family Medicine, 25, 350–366.
   PubMed Web of Science ®Google Scholar
• Savoiardo, M., Strada, L., Girotti, F., D’Incerti, L., Sberna, M., Soliveri, P. & Balzarini, L. (1989). MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. Journal of Computer Assisted Tomography, 13, 555–560.
   PubMed Web of Science ®Google Scholar
• Seritan, A.L., Mendez, M.F., Silverman, D.H., Hurley, R.A. & Taber, K.H. (2004). Functional imaging as a window to dementia: Corticobasal degeneration. The Journal of Neuropsychiatry and Clinical Neurosciences, 16, 393–399.
   PubMed Web of Science ®Google Scholar
• Shibuya, N., Tachibana, H., Okuda, B., & Sugita, M. (2000). [Neuropsychological comparison between corticobasal degeneration and progressive supranuclear palsy]. [Comparative Study]. Nihon Ronen Igakkai zasshi. Japanese Journal of Geriatrics, 37, 541–547.
   PubMedGoogle Scholar
• Sixel-Doring, F., Schweitzer, M., Mollenhauer, B. & Trenkwalder, C. (2009). Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Medicine, 10, 407–415.
   PubMed Web of Science ®Google Scholar
• Snowden, J.S., Thompson, J.C., Stopford, C.L., Richardson, A.M., Gerhard, A., Neary, D. & Mann, D.M. (2011). The clinical diagnosis of early-onset dementias: Diagnostic accuracy and clinicopathological relationships. Brain, 134, 2478–2492.
   PubMed Web of Science ®Google Scholar
• Sorbi, S., Hort, J., Erkinjuntti, T., Fladby, T., Gainotti, G., Gurvit, H., … Scheltens, P. (2012). EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. European Journal of Neurology, 19, 1159–1179.
   PubMed Web of Science ®Google Scholar
• Steele, J.C., Richardson, J.C. & Olszewski, J. (1964). Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Archives of Neurology, 10, 333–359.
   PubMed Web of Science ®Google Scholar
• Sudmeyer, M., Pieperhoff, P., Ferrea, S., Krause, H., Groiss, S.J., Elben, S., … Schnitzler, A. (2012). Longitudinal deformation-based morphometry reveals spatio-temporal dynamics of brain volume changes in patients with corticobasal syndrome. PloS ONE, 7, e41873. doi: 10.1371/journal.pone.0041873
   Web of Science ®Google Scholar
• Teune, L.K., Bartels, A.L., de Jong, B.M., Willemsen, A.T., Eshuis, S.A., de Vries, J.J., … Leenders, K.L. (2010). Typical cerebral metabolic patterns in neurodegenerative brain diseases. Movement disorders: official Journal of the Movement Disorder Society, 25, 2395–2404.
   PubMed Web of Science ®Google Scholar
• Vanvoorst, W. A., Greenaway, M. C., Boeve, B. F., Ivnik, R. J., Parisi, J. E., Eric Ahlskog, J., … Josephs, K. A. (2008). Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy. [Letter Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Parkinsonism & related disorders, 14, 376–378.
   PubMed Web of Science ®Google Scholar
• Wenning, G.K., Litvan, I., Jankovic, J., Granata, R., Mangone, C.A., McKee, A., Pearce, R.K. (1998). Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. Journal of Neurology, Neurosurgery, and Psychiatry, 64, 184–189.
   PubMed Web of Science ®Google Scholar
• Whitwell, J.L., Jack, C.R., Jr, Boeve, B.F., Parisi, J.E., Ahlskog, J.E., Drubach, D.A., … Josephs, K.A. (2010). Imaging correlates of pathology in corticobasal syndrome. Neurology, 75, 1879–1887.
   PubMed Web of Science ®Google Scholar
• Whitwell, J.L., Jack, C.R., Jr, Parisi, J.E., Knopman, D.S., Boeve, B.F., Petersen, R.C., … Josephs, K.A. (2007). Rates of cerebral atrophy differ in different degenerative pathologies. Brain, 130, 1148–1158.
   PubMedGoogle Scholar
• Williams, D.R. & Lees, A.J. (2009). Progressive supranuclear palsy: Clinicopathological concepts and diagnostic challenges. Lancet Neurology, 8, 270–279.
   PubMed Web of Science ®Google Scholar
• Wimo, A. & Prince, M. (Producer) (2010). The global economic impact of dementia. World Alzheimer Report 2010. Retrieved from: http://www.alz.org/documents/national/world_alzheimer_report_2010_summary(1).pdf
   Google Scholar
• Woolley, J.D., Khan, B.K., Murthy, N.K., Miller, B.L. & Rankin, K.P. (2011). The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: Rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. Journal of Clinical Psychiatry, 72, 126–133.
   PubMed Web of Science ®Google Scholar
• Yatabe, Y., Hashimoto, M., Kaneda, K., Honda, K., Ogawa, Y., Yuuki, S., … Ikeda, M. (2011). Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. [Comparative Study Research Support, Non-U.S. Govt]. Psychogeriatrics: the official Journal of the Japanese Psychogeriatric Society, 11, 54–59.
   PubMed Web of Science ®Google Scholar
• Zahodne, L.B., Bernal-Pacheco, O., Bowers, D., Ward, H., Oyama, G., Limotai, N., … Okun, M.S. (2012). Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease? Journal of Neuropsychiatry and Clinical Neurosciences, 24, 326–330.
   PubMed Web of Science ®Google Scholar
• Peters, M. E., Rosenberg, P. B., Steinberg, M., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A., … Lyketsos, C. G. (2012). Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 20, 416–424. doi: 10.1097/JGP.0b013e318211057d.
   PubMed Web of Science ®Google Scholar